IV Disposable Market Upcoming Trends and Analysis Report 2023 to 2033

According to Future Market Insights report, the worldwide IV Disposable Market demand is estimated to develop at a CAGR of 11.8% during the forecast period. The market value is expected to rise from US$ 17.0 billion in 2023 to US$ 51.6 billion in 2033. The IV Disposable market was valued at US$ 15.5 billion by the end of 2022 and is expected to expand 9.6% year on year in 2023.

With the increasing use of infusion pumps in healthcare settings and home use, demand for items such as ventilators, infusion pumps, and accessories, which are used to treat patients, has seen a substantial demand increase. The global COVID-19 pandemic has had an unprecedented impact on the same.

IV therapies can now be used effectively and safely because to technological advancements in IV therapy products and a growing focus on cost containment and cost-effectiveness at healthcare facilities. Over the projected period, the market for Disposable IV treatment products is anticipated to rise due to patients' growing preference for safety-enhancing pumping devices and needleless technologies.

The use of Disposable products can help to reduce the risk of healthcare-associated infections, which has become a major concern for healthcare providers. This has led to a growing demand for Disposable products such as catheters, syringes, and other medical devices.

Overall, these factors are contributing to the growth of the IV Disposable market, and are expected to continue to drive demand for effective and innovative treatment options in the coming years.

Key Companies Profiled:

  • B. Braun Melsungen AG
  • Baxter
  • 3M
  • Terumo Corporation
  • Nipro Corporation
  • Teleflex Incorporated
  • Becton, Dickinson and Company
  • Smiths Medical/ICU Medical
  • Moog Inc
  • AngioDynamics.
  • Fresenius SE & Co. KgaA
  • arcomed ag

Browse Detail Summary Of Research Report@ https://www.futuremarketinsights.com/reports/iv-disposables-market

Key Segments Covered in IV Disposable Market Industry Research:

By Product:

  • Intravenous Administration Set
  • IV Fluid Solution Bags
  • IV Cannula
  • Infusion Sets
  • Infusion Pumps
  • Catheter Needles
  • Securement Devices
  • Others (Stopcocks, connectors, Extention Tubes)

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Care Settings

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more